MADISON TANNER: Open Payments
NPI 1033787122 · DUBLIN, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,628 in 104 payments from 16 companies in 2025. Trend: 2023 $1,987 · 2024 $2,585 · 2025 $2,628
Food & beverage: $2,612Education: $16
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $576 |
| UCB, Inc. | 17 | $498 |
| Organon LLC | 4 | $292 |
| GENZYME CORPORATION | 7 | $200 |
| Regeneron Healthcare Solutions, Inc. | 10 | $188 |
| Lilly USA, LLC | 6 | $155 |
| Novartis Pharmaceuticals Corporation | 6 | $129 |
| PFIZER INC. | 1 | $116 |
| Janssen Biotech, Inc. | 4 | $88 |
| Galderma Laboratories, L.P. | 4 | $86 |
Products named: Bimzelx, SKYRIZI, DUPIXENT, VTAMA, RINVOQ, COSENTYX, TALTZ, LITFULO.
Industry payments across GA — which companies pay providers there.
